Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-136261
Filing Date
2025-06-06
Accepted
2025-06-06 06:04:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d933807ddefa14a.htm DEFA14A 12908
2 GRAPHIC g933807g0606033117828.jpg GRAPHIC 3629
3 GRAPHIC g933807g0606033118216.jpg GRAPHIC 2006
  Complete submission text file 0001193125-25-136261.txt   22029
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 251028763
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)